Novel Laboratories is a progressive pharmaceutical company partnering with clients around the globe to develop and manufacture high-value, niche products. Novel has a strong focus on R&D and is capable of producing technically challenging generic and branded products across a wide range of therapeutic classes and dosage forms.
The company possesses a comprehensive range of in-house pharmaceutical technologies to develop products with significant barriers to entry. With a current capacity to product over one billion doses a year, Novel’s New Jersey based facility continues to grow with an expansion currently underway and scheduled for completion by the end of 2015.
Our partnerships with GAVIS Pharmaceuticals and Wintac Limited allow us to offer a full range of services ranging from specialty drug development and manufacturing to marketing and distribution.